These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 15221935

  • 1. Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.
    Chatterjee SJ, George B, Goebell PJ, Alavi-Tafreshi M, Shi SR, Fung YK, Jones PA, Cordon-Cardo C, Datar RH, Cote RJ.
    J Pathol; 2004 Jul; 203(3):762-70. PubMed ID: 15221935
    [Abstract] [Full Text] [Related]

  • 2. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein.
    Nielsen NH, Emdin SO, Cajander J, Landberg G.
    Oncogene; 1997 Jan 23; 14(3):295-304. PubMed ID: 9018115
    [Abstract] [Full Text] [Related]

  • 3. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
    Sarkar S, Jülicher KP, Burger MS, Della Valle V, Larsen CJ, Yeager TR, Grossman TB, Nickells RW, Protzel C, Jarrard DF, Reznikoff CA.
    Cancer Res; 2000 Jul 15; 60(14):3862-71. PubMed ID: 10919661
    [Abstract] [Full Text] [Related]

  • 4. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
    Sartor M, Steingrimsdottir H, Elamin F, Gäken J, Warnakulasuriya S, Partridge M, Thakker N, Johnson NW, Tavassoli M.
    Br J Cancer; 1999 Apr 15; 80(1-2):79-86. PubMed ID: 10389982
    [Abstract] [Full Text] [Related]

  • 5. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis.
    Ayhan S, Isisag A, Saruc M, Nese N, Demir MA, Kucukmetin NT.
    Hepatogastroenterology; 2010 Apr 15; 57(98):251-6. PubMed ID: 20583423
    [Abstract] [Full Text] [Related]

  • 6. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
    Okami K, Reed AL, Cairns P, Koch WM, Westra WH, Wehage S, Jen J, Sidransky D.
    Oncogene; 1999 Jun 10; 18(23):3541-5. PubMed ID: 10376532
    [Abstract] [Full Text] [Related]

  • 7. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
    Brambilla E, Moro D, Gazzeri S, Brambilla C.
    J Pathol; 1999 Aug 10; 188(4):351-60. PubMed ID: 10440744
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
    Geradts J, Kratzke RA, Niehans GA, Lincoln CE.
    Cancer Res; 1995 Dec 15; 55(24):6006-11. PubMed ID: 8521382
    [Abstract] [Full Text] [Related]

  • 9. The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node.
    Lodén M, Stighall M, Nielsen NH, Roos G, Emdin SO, Ostlund H, Landberg G.
    Oncogene; 2002 Jul 11; 21(30):4680-90. PubMed ID: 12096344
    [Abstract] [Full Text] [Related]

  • 10. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
    Shariat SF, Tokunaga H, Zhou J, Kim J, Ayala GE, Benedict WF, Lerner SP.
    J Clin Oncol; 2004 Mar 15; 22(6):1014-24. PubMed ID: 14981102
    [Abstract] [Full Text] [Related]

  • 11. Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma.
    Nakamura T, Ide H, Eguchi R, Hayashi K, Takasaki K.
    Hepatogastroenterology; 2003 Mar 15; 50(53):1321-6. PubMed ID: 14571727
    [Abstract] [Full Text] [Related]

  • 12. Expression of p16 and lack of pRB in primary small cell lung cancer.
    Yuan J, Knorr J, Altmannsberger M, Goeckenjan G, Ahr A, Scharl A, Strebhardt K.
    J Pathol; 1999 Nov 15; 189(3):358-62. PubMed ID: 10547597
    [Abstract] [Full Text] [Related]

  • 13. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
    Dreyling MH, Bullinger L, Ott G, Stilgenbauer S, Müller-Hermelink HK, Bentz M, Hiddemann W, Döhner H.
    Cancer Res; 1997 Oct 15; 57(20):4608-14. PubMed ID: 9377576
    [Abstract] [Full Text] [Related]

  • 14. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas.
    Lai S, El-Naggar AK.
    Lab Invest; 1999 Mar 15; 79(3):255-60. PubMed ID: 10092061
    [Abstract] [Full Text] [Related]

  • 15. Abnormal expression of Rb pathway-related proteins in salivary gland acinic cell carcinoma.
    Liu T, Zhu E, Wang L, Okada T, Yamaguchi A, Okada N.
    Hum Pathol; 2005 Sep 15; 36(9):962-70. PubMed ID: 16153458
    [Abstract] [Full Text] [Related]

  • 16. Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions.
    Brambilla E, Gazzeri S, Moro D, Lantuejoul S, Veyrenc S, Brambilla C.
    Clin Cancer Res; 1999 Feb 15; 5(2):243-50. PubMed ID: 10037171
    [Abstract] [Full Text] [Related]

  • 17. Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus.
    Lerma E, Esteller M, Herman JG, Prat J.
    Hum Pathol; 2002 Nov 15; 33(11):1120-5. PubMed ID: 12454817
    [Abstract] [Full Text] [Related]

  • 18. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
    Eissa S, Ahmed MI, Said H, Zaghlool A, El-Ahmady O.
    IUBMB Life; 2004 Sep 15; 56(9):557-64. PubMed ID: 15590562
    [Abstract] [Full Text] [Related]

  • 19. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.
    Geradts J, Ingram CD.
    Mod Pathol; 2000 Sep 15; 13(9):945-53. PubMed ID: 11007034
    [Abstract] [Full Text] [Related]

  • 20. Aberrant expression of cell-cycle regulatory proteins in human mesenchymal neoplasia.
    Creager AJ, Cohen JA, Geradts J.
    Cancer Detect Prev; 2001 Sep 15; 25(2):123-31. PubMed ID: 11341347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.